Clinical Trial Update: Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety of anti-diabetes mellitus drugs as monotherapy or in combination in Japanese subjects with Type 2 diabetes mellitus; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type2 Diabetes, High Blood Sugar | Phase 3 | Status: COMPLETED | Results posted: 2013-09-16